arrow
J

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center
H指数:153
被引数:9.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis

卵巢癌免疫基因组景观表征揭示了一种与高CST2表达相关且预后良好的子宫内膜样肿瘤亚群

2026-01-010
OA
APOBEC3 mutagenesis drives therapy resistance in breast cancer

APOBEC3诱变驱动乳腺癌的疗法抗性。

2025-05-160
OA
The cold immunological landscape of ATM-deficient cancers

ATM缺陷型癌症的冷免疫景观

2025-05-110
OA
Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test

视网膜母细胞瘤患者接受cfDNA检测中的RB1嵌合现象的检测与特征分析

2025-05-081
PRE
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
2025-01-240
OAAI
Advancing Global Health Equity in Oncology Clinical Trial Access
2024-09-240
PRE
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism
2024-08-150
OAAI
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms
2024-08-060
PRE
International survey on invasive lobular breast cancer identifies priority research questions
2024-07-201
OAAI
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

晚期癌症2024年患者使用下一代测序 (NGS) 的建议: 来自ESMO精密医学工作组的报告

2024-07-0121
OAAI
Novel Mechanisms of CDH1 Inactivation in Breast Invasive Lobular Carcinoma Unveiled by the Integration of Artificial Intelligence and Genomics
2024-05-020
PRE
Results from a pilot study exploring ctDNA detection using a tumor-informed assay in the monarchE trial of adjuvant abemaciclib with endocrine therapy in HR+, HER2-, node-positive, high-risk early breast cancer
2024-05-020
PRE